Complete Filing Data
UPEXI, INC. reported Net Income Loss of -$13.68 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean UPEXI, INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$13.7M | -$23.7M | -$17.5M | -$2.0M | $3.0M | -$5.4M |
| Selling And Marketing Expense | $4.0M | $6.0M | $6.1M | $5.1M | $2.4M | $1.4M |
| Revenues | $15.8M | $26.0M | $36.4M | $23.1M | $24.1M | $7.4M |
| Other Nonoperating Income Expense | -$10.7K | -$16.4K | -$4.7M | $101.1K | -$269.4K | $546.5K |
| Operating Income Loss | -$12.5M | -$22.5M | -$12.3M | -$6.5M | $1.4M | -$4.8M |
| Operating Expenses | $23.4M | $35.3M | $33.3M | $21.4M | $10.5M | $7.4M |
| Gross Profit | $10.9M | $12.8M | $21.0M | $14.9M | $11.9M | $2.6M |
| General And Administrative Expense | $11.9M | $6.8M | $6.9M | $9.1M | $6.4M | $6.0M |
| Cost Of Revenue | $4.9M | $13.2M | $15.4M | $8.2M | $12.2M | $4.8M |
| Interest Income Expense Net | -$1.2M | -$3.1M | -$4.7M | -$202.1K | $530.4K | $138.4K |
| Income Tax Expense Benefit | $0.00 | -$332.1K | $3.0M | $518.4K | $1.3M | $0.00 |
| Income Loss From Continuing Operations Per Basic Share | -$1.73 | -$24.60 | -$15.56 | -$0.36 | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$13.7M | -$25.6M | -$17.0M | -$6.4M | ||
| Income Loss From Discontinued Operations Net Of Tax Per Basic Share | $0.00 | $1.13 | -$1.53 | $5.0M | ||
| Income Loss From Continuing Operations Per Diluted Share | -$1.73 | -$24.60 | -$15.56 | -$0.07 | ||
| Income Loss From Discontinued Operations Net Of Tax Per Diluted Share | $0.00 | $1.13 | -$1.53 | -$0.36 | ||
| Income Loss From Discontinued Operations Net Of Tax | $0.00 | $1.2M | -$1.4M | -$1.2M | ||
| Income Loss From Continuing Operations | -$13.7M | -$25.3M | -$13.9M | -$5.9M | ||
| Operating Lease Impairment Loss | -$270.0K | $290.0K | ||||
| Income Taxes Paid Net | $0.00 | $0.00 | $0.00 | $656.0K | ||
| Deferred Revenue Current | $235.3K | $0.00 | $486.0K | $473.3K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$178.9M | $66.7M | -$3.8M | -$1.3M | -$1.6M | -$4.1M | -$2.4M | -$1.4M | -$1.8M | $2.6M | -$2.7M | -$52.7K | $64.8K | $511.7K | $966.8K | $102.5K | -$809.1K | ||
| Selling And Marketing Expense | $915.8K | $1.1M | $1.0M | $950.0K | $1.0M | $1.3M | $1.5M | $1.8M | $2.3M | $3.3M | $1.7M | $1.1M | $1.7M | $1.0M | $656.2K | $459.4K | $365.3K | ||
| Revenues | $8.1M | $9.2M | $3.2M | $4.0M | $4.4M | $5.2M | $7.5M | $8.3M | $21.9M | $26.7M | $11.2M | $4.4M | $5.0M | $3.9M | $6.3M | $4.2M | $2.9M | ||
| Other Nonoperating Income Expense | $44.6K | $292.2K | -$244.4K | $0.00 | $0.00 | -$746.9K | -$1.0M | -$853.3K | $152.4K | -$1.8M | $431.7K | $14.2K | -$48.5K | $15.5K | -$48.5K | $345.8K | -$49.0K | ||
| Operating Income Loss | -$175.4M | $69.2M | -$3.6M | -$1.1M | -$1.3M | -$5.0M | -$2.6M | -$1.5M | -$2.1M | -$1.7M | -$2.4M | -$1.5M | -$2.5M | -$879.1K | $1.0M | -$243.3K | -$760.1K | ||
| Operating Expenses | $182.1M | -$60.9M | $5.1M | $4.0M | $4.3M | $6.3M | $7.2M | $6.9M | $9.7M | $11.8M | $8.2M | $4.9M | $6.8M | $3.5M | $2.4M | $2.2M | $2.1M | ||
| Gross Profit | $6.7M | $8.3M | $1.6M | $3.0M | $2.9M | $1.3M | $4.6M | $5.4M | $7.6M | $10.1M | $5.8M | $3.3M | $4.3M | $2.6M | $3.4M | $1.9M | $1.3M | ||
| General And Administrative Expense | $5.5M | $9.3M | $2.6M | $1.5M | $1.4M | $1.8M | $1.6M | $1.6M | $2.6M | $2.5M | $2.1M | $2.0M | $3.0M | $1.6M | $1.3M | $1.7M | $1.7M | ||
| Cost Of Revenue | $1.3M | $956.7K | $1.6M | $1.0M | $1.4M | $4.0M | $2.9M | $2.8M | $14.3M | $16.7M | $5.4M | $1.1M | $711.2K | $1.3M | $3.0M | $2.2M | $1.6M | ||
| Interest Income Expense Net | -$3.6M | -$2.7M | -$245.1K | -$228.1K | -$290.4K | -$736.6K | -$1.0M | $874.2K | $152.4K | -$1.8M | $433.5K | -$19.7K | -$48.5K | -$16.0K | -$48.5K | -$42.0K | -$42.7K | ||
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.5M | $694.8K | $472.4K | -$496.9K | -$755.3K | $708.2K | -$1.4M | -$493.9K | $258.9K | $0.00 | $0.00 | |||
| Income Loss From Continuing Operations Per Basic Share | -$2.94 | $1.21 | -$2.87 | -$1.24 | -$1.55 | -$4.19 | -$3.00 | -$1.81 | -$0.08 | $0.19 | -$0.16 | -$0.01 | -$0.32 | $0.03 | |||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$178.9M | $66.7M | -$3.8M | -$1.3M | -$1.6M | -$5.8M | -$3.6M | -$2.3M | -$2.0M | -$3.5M | -$2.7M | -$1.6M | -$2.6M | $894.7K | |||||
| Income Loss From Discontinued Operations Net Of Tax Per Basic Share | $0.00 | $0.00 | $0.00 | $0.26 | $1.00 | $0.10 | -$0.02 | -$0.04 | -$0.04 | $0.01 | $0.29 | $0.07 | |||||||
| Income Loss From Continuing Operations Per Diluted Share | -$2.94 | $0.76 | -$2.87 | -$1.24 | -$1.55 | -$4.19 | -$3.00 | -$1.81 | -$0.11 | $0.17 | -$0.16 | -$0.01 | -$0.32 | $0.03 | |||||
| Income Loss From Discontinued Operations Net Of Tax Per Diluted Share | $0.00 | $0.00 | $0.00 | $0.26 | $1.00 | $0.10 | $0.02 | -$0.30 | $0.00 | $0.01 | $0.29 | $0.07 | |||||||
| Income Loss From Discontinued Operations Net Of Tax | $0.00 | $0.00 | $268.2K | $549.1K | -$2.0M | -$287.1K | -$292.9K | -$2.8M | $147.6K | $2.8M | |||||||||
| Income Loss From Continuing Operations | $66.7M | -$3.8M | -$1.3M | -$1.6M | -$4.3M | -$2.9M | -$1.8M | -$1.5M | $3.3M | -$644.6K | -$200.3K | -$3.1M | $511.7K | ||||||
| Operating Lease Impairment Loss | -$270.0K | $0.00 | $0.00 | $290.0K | |||||||||||||||
| Income Taxes Paid Net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||
| Deferred Revenue Current | $47.3K | $51.3K | $13.2K | $23.9K | $139.0K | $178.0K | $111.5K | $104.1K | $48.2K | $31.7K | $121.0K | $105.8K | $257.0K | $959.3K | $864.7K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $90.1M | $6.5M | $27.8M | $28.8M | $21.2M | $2.2M | $6.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $4.5M | $7.1M | $14.5M | ||||
| Inventory Write Down | $748.9K | $1.8M | $119.0K | $1.0M | $375.0K | ||
| Goodwill | $848.9K | $2.9M | $4.6M | $2.4M | |||
| Notes Payable Current | $0.00 | $338.5K | $749.8K | $447.1K | |||
| Inventory Net | $1.4M | $4.8M | $2.1M | $1.4M | |||
| Retained Earnings Accumulated Deficit | -$46.9M | -$23.2M | -$6.3M | -$4.2M | -$7.1M | ||
| Property Plant And Equipment Net | $2.4M | $2.8M | $7.3M | $2.8M | $1.7M | ||
| Preferred Stock Value | $1.00 | $25.00 | $500.00 | $500.00 | $0.00 | ||
| Other Assets Noncurrent | $278.4K | $76.7K | $75.6K | $49.1K | $37.1K | ||
| Other Assets | $12.1M | $33.8M | $31.4M | $9.0M | $3.8M | ||
| Operating Lease Right Of Use Asset | $2.4M | $410.5K | $844.9K | $417.4K | $294.8K | ||
| Operating Lease Liability Noncurrent | $1.7M | $0.00 | $700.4K | $217.4K | $338.0K | ||
| Operating Lease Liability Current | $1.0M | $454.1K | $183.9K | $199.5K | $461.1K | ||
| Liabilities Noncurrent | $4.3M | $13.6M | $9.6M | $217.4K | $703.4K | ||
| Liabilities Current | $12.7M | $22.4M | $10.1M | $5.8M | $3.5M | ||
| Liabilities And Stockholders Equity | $23.5M | $63.8M | $48.5M | $27.3M | $6.4M | ||
| Intangible Assets Net Excluding Goodwill | $239.9K | $6.9M | $8.8M | $1.8M | $1.2M | ||
| Assets Current | $11.4M | $30.0M | $17.1M | $18.3M | $2.6M | ||
| Assets | $23.5M | $63.8M | $48.5M | $27.3M | $6.4M | ||
| Accrued Liabilities Current | $736.4K | $2.4M | $816.6K | $296.0K | $221.7K | ||
| Accrued Bonuses Current | $1.1M | $533.8K | $489.7K | $1.0M | $195.4K | ||
| Accounts Receivable Net Current | $606.9K | $1.1M | $939.9K | $1.3M | $165.1K | ||
| Accounts Payable Current | $481.6K | $1.0M | $1.6M | $1.6M | $484.3K | ||
| Common Stock Value | $11.00 | $16.7K | $15.3K | $10.2K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q2 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $48.7M | $210.8M | $90.1M | $1.9M | $3.8M | $5.0M | $6.5M | $22.1M | $25.5M | $27.6M | $27.8M | $37.0M | $36.7M | $27.0M | $28.8M | $28.4M | $29.5M | $24.8M | $21.2M | $3.7M | $2.3M | $1.9M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.6M | $2.2M | $3.0M | $230.4K | $406.3K | $1.8M | $661.4K | $224.3K | $566.7K | $519.5K | $1.2M | $4.5M | $3.3M | $4.5M | $6.6M | $13.0M | ||||||||
| Inventory Write Down | $1.7M | $35.5K | $0.00 | $0.00 | ||||||||||||||||||||
| Goodwill | $673.9K | $848.9K | $848.9K | $848.9K | $848.9K | $848.9K | $10.8M | $11.8M | $11.7M | $15.1M | $15.3M | $6.2M | $8.5M | $8.5M | $3.7M | $2.4M | $493.1K | |||||||
| Notes Payable Current | $560.0K | $560.0K | $560.0K | $420.0K | $280.0K | $140.0K | $5.5M | $4.2M | $4.3M | $9.2M | $2.1M | $5.4M | $506.3K | $1.0M | $1.0M | $183.6K | ||||||||
| Inventory Net | $728.3K | $1.0M | $1.2M | $1.3M | $2.2M | $1.6M | $8.8M | $14.7M | $13.8M | $10.1M | $6.8M | $6.1M | $11.6M | $3.6M | $3.7M | $3.1M | ||||||||
| Retained Earnings Accumulated Deficit | -$172.7M | $6.2M | -$60.5M | -$53.6M | -$49.8M | -$48.5M | -$31.1M | -$27.0M | -$24.6M | -$7.8M | -$6.2M | -$8.9M | -$3.6M | -$3.6M | -$3.7M | |||||||||
| Property Plant And Equipment Net | $543.2K | $1.9M | $2.1M | $2.0M | $2.1M | $2.3M | $7.5M | $7.6M | $7.7M | $7.6M | $7.2M | $7.4M | $7.7M | $7.4M | $2.9M | |||||||||
| Preferred Stock Value | $2.00 | $2.00 | $2.00 | $150.00 | $25.00 | $25.00 | $500.00 | $500.00 | $500.00 | $500.00 | $500.00 | $500.00 | $500.00 | $500.00 | $500.00 | |||||||||
| Other Assets Noncurrent | $218.7K | $200.7K | $192.1K | $192.1K | $199.9K | $206.4K | $368.0K | $441.8K | $365.1K | $118.0K | $56.7K | $414.0K | $69.1K | $69.1K | $49.1K | |||||||||
| Other Assets | $99.9M | $199.4M | $67.0M | $11.1M | $11.4M | $11.8M | $39.7M | $39.6M | $40.3M | $53.7M | $54.5M | $30.3M | $22.9M | $23.1M | $11.4M | |||||||||
| Operating Lease Right Of Use Asset | $636.4K | $1.6M | $1.7M | $1.9M | $2.1M | $2.2M | $1.5M | $1.7M | $2.0M | $678.1K | $608.5K | $843.9K | $588.1K | $648.6K | $323.9K | |||||||||
| Operating Lease Liability Noncurrent | $460.1K | $1.1M | $1.1M | $1.8M | $1.8M | $1.8M | $1.1M | $1.2M | $0.00 | $449.9K | $375.6K | $589.0K | $338.2K | $395.1K | $183.7K | |||||||||
| Operating Lease Liability Current | $263.7K | $521.7K | $691.0K | $165.1K | $618.2K | $781.8K | $803.6K | $823.7K | $5.7M | $272.1K | $187.8K | $274.8K | $242.9K | $248.6K | $136.9K | |||||||||
| Liabilities Noncurrent | $144.6M | $144.3M | $1.1M | $2.4M | $3.1M | $3.8M | $10.3M | $12.4M | $17.6M | $19.4M | $24.8M | $10.3M | $363.4K | $421.9K | $183.7K | |||||||||
| Liabilities Current | $77.9M | $64.6M | $32.6M | $10.8M | $10.6M | $9.8M | $24.2M | $24.3M | $20.0M | $17.7M | $15.1M | $11.7M | $4.4M | $5.3M | $4.2M | |||||||||
| Liabilities And Stockholders Equity | $271.1M | $419.7M | $123.8M | $15.1M | $17.5M | $18.6M | $56.5M | $62.2M | $65.2M | $73.8M | $76.6M | $49.1M | $33.2M | $35.2M | $29.2M | |||||||||
| Intangible Assets Net Excluding Goodwill | $874.7K | $143.9K | $163.1K | $182.3K | $201.5K | $220.7K | $9.5M | $11.3M | $12.4M | $17.3M | $18.7M | $12.7M | $4.8M | $5.2M | $3.2M | |||||||||
| Assets Current | $171.3M | $220.3M | $56.8M | $4.0M | $6.1M | $6.8M | $16.8M | $22.6M | $24.9M | $20.1M | $22.1M | $18.8M | $10.3M | $12.1M | $17.8M | |||||||||
| Assets | $271.1M | $419.7M | $123.8M | $15.1M | $17.5M | $18.6M | $56.5M | $62.2M | $65.2M | $73.8M | $76.6M | $49.1M | $33.2M | $35.2M | $29.2M | |||||||||
| Accrued Liabilities Current | $2.0M | $947.1K | $356.1K | $223.5K | $222.1K | $317.2K | $2.6M | $2.7M | $3.9M | $4.2M | $3.9M | $1.8M | $755.7K | $873.6K | $276.4K | |||||||||
| Accrued Bonuses Current | $3.1M | $3.2M | $3.5M | $1.1M | $837.7K | $952.6K | $841.1K | $495.2K | $513.9K | $889.6K | $718.8K | $695.3K | $722.1K | $679.0K | $859.3K | |||||||||
| Accounts Receivable Net Current | $594.6K | $284.3K | $157.5K | $180.9K | $1.2M | $801.4K | $4.7M | $5.4M | $9.8M | $5.3M | $8.9M | $1.3M | $1.5M | $1.2M | $1.1M | |||||||||
| Accounts Payable Current | $665.8K | $2.2M | $1.0M | $1.4M | $1.0M | $575.2K | $2.1M | $3.0M | $4.6M | $2.6M | $4.2M | $2.1M | $1.3M | $895.8K | $1.0M | |||||||||
| Common Stock Value | $632.00 | $589.00 | $383.00 | $1.4K | $1.0K | $1.0K | $20.9K | $20.3K | $20.3K | $20.2K | $18.1K | $18.0K | $16.7K | $16.1K | $16.4K | $15.7K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Financing Cash Flow * | $110.0M | -$353.8K | -$285.3K | $3.7M | $12.0M | $2.8M |
| Investing Cash Flow * | -$99.3M | -$3.4M | -$2.6M | -$10.9M | -$1.3M | -$1.5M |
| Operating Cash Flow * | -$8.4M | -$101.4K | $202.7K | -$180.8K | $2.9M | -$4.2M |
| Share Based Compensation | $2.1M | $1.2M | $3.7M | $3.3M | $611.4K | $372.8K |
| Payments To Acquire Property Plant And Equipment | $387.8K | $932.6K | $937.6K | $5.5M | $1.4M | $1.9M |
| Increase Decrease In Inventories | $470.2K | -$2.7M | $1.4M | -$2.8M | -$846.7K | $310.4K |
| Increase Decrease In Accounts Receivable | $484.6K | -$675.7K | $364.7K | $285.0K | -$1.1M | $95.7K |
| Increase Decrease In Deferred Revenue | -$222.1K | $101.3K | $0.00 | -$478.4K | -$99.8K | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$222.0K | -$106.6K | -$287.8K | $284.7K | -$313.2K | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $2.9M | -$944.0K | $389.5K | -$446.6K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $39.4M | -$2.7M | -$325.9K | $1.3M | -$150.0K | -$12.0K | ||||||||||
| Investing Cash Flow * | -$30.3M | $5.8M | $145.3K | -$2.6M | -$2.2M | $270.7K | ||||||||||
| Operating Cash Flow * | -$9.8M | -$2.0M | -$3.8M | -$2.5M | $817.4K | -$637.2K | ||||||||||
| Share Based Compensation | $8.3M | $5.8M | $521.4K | $32.6K | $141.3K | $212.8K | $330.6K | $421.9K | $1.1M | $1.1M | $927.3K | $854.0K | $852.5K | $593.1K | $226.0K | $93.2K |
| Payments To Acquire Property Plant And Equipment | $14.8K | $167.4K | $294.7K | $147.9K | $166.9K | $5.5K | ||||||||||
| Increase Decrease In Inventories | -$117.2K | $204.9K | $1.9M | -$912.5K | -$420.8K | -$269.8K | ||||||||||
| Increase Decrease In Accounts Receivable | $127.0K | $194.6K | $1.3M | -$180.5K | $19.7K | -$257.9K | ||||||||||
| Increase Decrease In Deferred Revenue | $38.2K | -$57.2K | $19.8K | $0.00 | $0.00 | |||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $1.4M | -$170.5K | -$306.4K | -$682.0K | $210.7K | |||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $2.2M | -$494.6K | $925.9K | $969.8K | $279.9K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Earnings Per Share Basic | $-1.73 | $-23.03 | $-18.94 | $-0.43 | $0.25 | $-0.53 |
| Weighted Average Number Of Shares Outstanding Basic | 7.9M | 1.0M | 893.9K | 16.2M | 11.9M | 10.1M |
| Earnings Per Share Diluted | $-1.73 | $-23.03 | $-18.94 | $-0.43 | $0.21 | $-0.53 |
| Weighted Average Number Of Diluted Shares Outstanding | 7.9M | 1.0M | 893.9K | 16.2M | 14.3M | |
| Common Stock Shares Outstanding | 4.01T | 1.0M | 1.0M | 15.3M | ||
| Common Stock Shares Issued | 1.0M | 1.0M | 15.3M | |||
| Preferred Stock Shares Issued | 25.0K | 25.0K | 500.0K | |||
| Preferred Stock Shares Authorized | 100.0M | 500.0K | 100.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Authorized | 300.0M | 5.0M | 100.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | |||
| Preferred Stock Shares Outstanding | 25.0K | 25.0K | 500.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share Basic | $-2.87 | $-1.24 | $-1.55 | $-4.03 | $-2.00 | $-1.34 | $-0.09 | $0.15 | $-0.16 | $0.00 | $-0.32 | $0.03 | $0.07 | $0.01 | $-0.08 | |||||
| Weighted Average Number Of Shares Outstanding Basic | 60.8M | 55.3M | 1.3M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 18.0M | 17.5M | 16.7M | 16.4M | 9.8M | 15.5M | 13.7M | 13.5M | 10.4M | |||
| Earnings Per Share Diluted | $-2.87 | $-1.24 | $-1.55 | $-4.03 | $-2.00 | $-1.34 | $-0.11 | $0.14 | $-0.16 | $0.00 | $-0.32 | $0.03 | $0.07 | $0.01 | $-0.08 | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 60.8M | 88.5M | 1.3M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 18.0M | 19.0M | 16.7M | 17.8M | 9.8M | 17.2M | 14.0M | |||||
| Common Stock Shares Outstanding | 63.2M | 58.9M | 38.3M | 1.4M | 1.0M | 1.0M | 20.9M | 20.4M | 20.3M | 18.1M | 18.0M | 16.7M | 16.7M | 16.1M | 16.4M | 15.7M | 15.3M | |||
| Common Stock Shares Issued | 63.2M | 58.9M | 38.3M | 1.4M | 1.0M | 1.0M | 20.9M | 20.4M | 20.3M | 18.1M | 18.0M | 16.7M | 16.7M | 16.1M | 16.4M | 15.7M | 500.0K | 15.3M | ||
| Preferred Stock Shares Issued | 150.0K | 150.0K | 150.0K | 25.0K | 25.0K | 25.0K | 500.0K | 500.0K | 500.0K | 500.0K | 500.0K | 500.0K | 500.0K | 500.0K | 500.0K | 500.0K | 500.0K | |||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 1.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Authorized | 1.00B | 300.0M | 1.00B | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Preferred Stock Shares Outstanding | 150.0K | 150.0K | 150.0K | 25.0K | 25.0K | 25.0K | 500.0K | 500.0K | 500.0K | 500.0K | 500.0K | 500.0K | 500.0K | 500.0K | 500.0K | 500.0K | 500.0K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Depreciation | $681.0K | $1.3M | $913.2K | $574.3K | $303.5K | |
| Production And Distribution Costs | $4.7M | $8.6M | $9.5M | $2.2M | ||
| Depreciation And Amortization | $757.8K | $3.7M | $3.5M | $2.7M | $1.0M | $611.3K |
| Stock Based Compensation Amortization Of Stock Options | $957.1K | $3.7M | ||||
| Additional Paid In Capital | $53.4M | $51.5M | $35.0M | $25.4M | $7.3M | |
| Interest Paid Net | $805.9K | $839.0K | $2.3M | $64.5K | ||
| Income Loss On Discontinued Operations Vitamedica | $0.00 | $213.6K | -$382.4K | |||
| Income Loss On Discontinued Operations Interactive Offers | $0.00 | -$187.0K | -$1.7M | |||
| Other Incom Expenses Net | -$16.4K | $38.3K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation | $134.4K | $135.9K | $198.5K | $220.6K | $239.9K | $306.2K | $317.7K | $277.6K | $225.9K | $241.0K | $194.5K | $115.0K | $159.1K | $87.5K | $71.9K | ||
| Production And Distribution Costs | $924.2K | $887.6K | $990.0K | $1.3M | $1.5M | $2.1M | $2.5M | $2.1M | $2.4M | $3.6M | $2.5M | $605.4K | $821.6K | $111.8K | |||
| Depreciation And Amortization | $155.1K | $259.1K | $936.5K | $924.4K | $156.3K | $279.9K | |||||||||||
| Stock Based Compensation Amortization Of Stock Options | $521.4K | $32.6K | $141.3K | $330.6K | $421.9K | ||||||||||||
| Additional Paid In Capital | $222.2M | $204.6M | $150.6M | $55.5M | $53.5M | $53.5M | $53.1M | $52.4M | $52.1M | $44.9M | $43.1M | $36.0M | $32.0M | $33.1M | $28.4M | ||
| Interest Paid Net | $1.9M | $84.4K | $94.9K | $239.1K | $0.00 | ||||||||||||
| Income Loss On Discontinued Operations Vitamedica | $0.00 | $0.00 | $0.00 | $82.0K | $88.5K | $69.4K | |||||||||||
| Income Loss On Discontinued Operations Interactive Offers | $0.00 | $0.00 | $0.00 | -$103.3K | $0.00 | -$193.0K | |||||||||||
| Other Incom Expenses Net | $676.00 | $0.00 | $0.00 | -$10.4K | -$9.9K | -$9.8K |
Most recent annual filing with the SEC: September 24, 2025
Data sourced from SEC EDGAR public filings as of August 6, 2026.